Health1 month ago
Novavax Surpasses Expectations with Strong Q4 2025 Revenue Results
Novavax, the biotechnology company known for its COVID-19 vaccine, reported stronger-than-expected results for the fourth quarter of 2025, leading to an increase in its stock price...